Trials / Completed
CompletedNCT02511262
Detection of Mycoplasma Pneumoniae
Clinical Trial Protocol for the Illumigene® Mycoplasma Direct Assay
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 471 (actual)
- Sponsor
- Meridian Bioscience, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this Clinical Trial is to define the methods to be used to document that illumigene® Mycoplasma Direct meets its intended use claims, using the illumipro instrument, with throat swab samples collected from symptomatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | illumigene® Mycoplasma Direct, illumipro-10 | DNA amplification assay |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-01-01
- First posted
- 2015-07-30
- Last updated
- 2016-02-08
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02511262. Inclusion in this directory is not an endorsement.